Abridge AI Inc
 | |
| Industry | Healthcare technology |
|---|---|
| Founded | 2018 |
| Founder |
|
| Headquarters | Pittsburgh, Pennsylvania |
| Website | abridge |
Abridge AI Inc. is an American healthcare technology company specializing in generative artificial intelligence (AI) solutions for clinical documentation. Founded in 2018, the company has developed AI-powered tools that transcribe and summarize patient-clinician conversations into structured clinical notes, aiming to streamline workflows and reduce administrative burdens in healthcare settings.[1]
History
Abridge AI was established in 2018 by Shivdev Rao, MD, Florian Metze, and Sandeep Konam. Headquartered in Pittsburgh, Pennsylvania, the company's mission is to enhance understanding in healthcare through purpose-built AI solutions. Initially focused on transforming medical conversations into actionable insights, Abridge has since evolved to offer enterprise-grade AI platforms integrated with electronic medical records (EMR) systems.[2]
Products and Technology
Abridge's flagship product is an AI-powered platform designed to capture and summarize clinical conversations in real-time. Utilizing machine learning and natural language processing, the platform generates structured clinical notes that integrate seamlessly with EMR systems like Epic. This technology aims to improve documentation efficiency, reduce clinician burnout, and enhance patient care by allowing healthcare providers to focus more on patient interactions.[3][4]
In 2025, Abridge introduced a new contextual reasoning engine to further streamline clinical and financial workflows at the point of care. This advancement reflects the company's commitment to pioneering generative AI applications in healthcare.[5]
Funding and Valuation
Abridge has secured significant funding to support its growth and technological advancements.
- Series C (2024): Secured $150 million in a round led by Lightspeed Venture Partners, with participation from Redpoint Ventures, IVP, Spark Capital, Union Square Ventures, Bessemer Venture Partners, and others.
- Series D (2025): Announced a $250 million investment co-led by Elad Gil and IVP, with contributions from Bessemer Venture Partners, CapitalG, CVS Health Ventures, and Nvidia's NVentures.
As of February 2025, Abridge's valuation is estimated between $1.52 billion and $2.89 billion.
Partnerships and Deployments
Abridge's AI platform has been adopted by numerous healthcare systems across the United States, including:
- Mayo Clinic: Expanded use of Abridge's AI platform enterprise-wide to over 2,000 physicians.
- Kaiser Permanente: Launched a large-scale generative AI project in collaboration with Abridge.
- Duke Health: Partnered with Abridge to improve clinician efficiency and patient care.
- Johns Hopkins Medicine: Deployed Abridge's AI platform for clinical documentation across its enterprise.
References
- ↑ "How Abridge became one of the most talked-about healthcare AI startups". TechCrunch. Verizon Media. 2024-06-18. Retrieved 2025-04-12.
- ↑ "Abridge scores $250M series D; ambient AI tech now in use at 100+ health systems". Fierce Healthcare. Questex. 2024-06-18. Retrieved 2025-04-12.
- ↑ "Use of Abridge AI in Physician Notetaking Significantly Improves Patient and Clinician Experience at UChicago Medicine". Business Wire. Berkshire Hathaway. 2024-12-12. Retrieved 2025-04-12.
- ↑ "Meet the doctor who built a $250 million AI health startup". Fortune. Fortune Media IP Limited. 2025-02-17. Retrieved 2025-04-12.
- ↑ "Healthcare startup Abridge raises $250 million to enhance AI capabilities". Reuters. Thomson Reuters. 2025-02-17. Retrieved 2025-04-12.